GL1X · GenesisL1 explorer

MolNFT v1 · #165461 · protein

Human CD73 (ecto 5'-nucleotidase) in complex with PSB12646 (an aopcp derivative, compound 20 in publication) in the closed state

6TWA: “Human CD73 (ecto 5'-nucleotidase) in complex with PSB12646 (an aopcp derivative, compound 20 in publication)…”. X-ray diffraction, 3 ligands (O02, ZN, CA), 4 pockets (best druggability 0.74). MolNFT v1 #165461 on GenesisL1: 3D…

PDB
6TWA
Type
protein
Length
519 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
5'-nucleotidase
EC
3.1.3.5
UniProt
P21589
Ligands
O02, ZN, CA
Pockets
4 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A5'-nucleotidase (EC 3.1.3.5)protein51930% helix, 27% strandP21589

Ligands and binding sites

  • O02 · [[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-diazanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17180.740.8083O02
2930.650.9126empty
3590.290.7415empty
4560.250.7221empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6TWA · Human CD73 (ecto 5'-nucleotidase) in complex with PSB12646 (an AOPCP derivative, compound… · the same entry in another collection · chain A against A, TM-score 1.00
  • P21589 · AlphaFold monomer V2.0 prediction for 5'-nucleotidase (P21589) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.